- Home
- GERN vs FLNG Comparison
GERN vs FLNG Comparison
Compare GERN & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- FLNG
- Stock Information
- Founded
- GERN 1990
- FLNG 2006
- Country
- GERN United States
- FLNG Bermuda
- Employees
- GERN N/A
- FLNG N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- FLNG Marine Transportation
- Sector
- GERN Health Care
- FLNG Consumer Discretionary
- Exchange
- GERN Nasdaq
- FLNG Nasdaq
- Market Cap
- GERN 1.5B
- FLNG 1.3B
- IPO Year
- GERN 1996
- FLNG N/A
- Fundamental
- Price
- GERN $2.57
- FLNG $23.30
- Analyst Decision
- GERN Strong Buy
- FLNG Hold
- Analyst Count
- GERN 11
- FLNG 1
- Target Price
- GERN $6.82
- FLNG $23.00
- AVG Volume (30 Days)
- GERN 12.4M
- FLNG 491.1K
- Earning Date
- GERN 02-26-2025
- FLNG 02-04-2025
- Dividend Yield
- GERN N/A
- FLNG 12.87%
- EPS Growth
- GERN N/A
- FLNG N/A
- EPS
- GERN N/A
- FLNG 2.18
- Revenue
- GERN $29,480,000.00
- FLNG $356,349,000.00
- Revenue This Year
- GERN $31,918.56
- FLNG N/A
- Revenue Next Year
- GERN $289.41
- FLNG $3.58
- P/E Ratio
- GERN N/A
- FLNG $10.69
- Revenue Growth
- GERN 9199.68
- FLNG N/A
- 52 Week Low
- GERN $1.64
- FLNG $20.85
- 52 Week High
- GERN $5.34
- FLNG $30.48
- Technical
- Relative Strength Index (RSI)
- GERN 31.98
- FLNG 39.21
- Support Level
- GERN $2.49
- FLNG $23.73
- Resistance Level
- GERN $2.84
- FLNG $24.81
- Average True Range (ATR)
- GERN 0.15
- FLNG 0.66
- MACD
- GERN -0.01
- FLNG -0.31
- Stochastic Oscillator
- GERN 13.33
- FLNG 13.48
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with state-of-the-art tonnage offering significant advantages in form of reduced fuel consumption and lowered boil-off rates.